Condition: Lobular Breast Carcinoma · Sponsor: Istituto Oncologico Veneto IRCCS
The NAPOLI Study is a retrospective multicenter observational study designed to characterize negative hormone receptor and apocrine lobular invasive breast cancer. The study will collect real-world clinicopathological, molecular, therapeutic and outcome data from patients diagnosed and treated at participating centers. The aim is to describe the clinical behavior, pathological features, receptor profile, treatments received and oncologic outcomes of this rare breast cancer subtype.
This description comes directly from the study's public registry record.
Massimo Ferrucci, MD PhD · 049 821 5500 · massimoferrucci@gmail.com
Daniele Passeri, MD · +39 333 383 9397 · daniele.passeri.1995@gmail.com
Always discuss trial participation with your own doctor first.
| Veneto Institute of Oncology | Padova, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07613151